FDA commissioner Robert Califf (Tom Williams/CQ Roll Call via AP Images)
December 8, 2022 02:21 PM ESTUpdated December 14, 10:57 AM
FDA+

FDA com­mis­sion­er on drug ap­provals: The prob­lem is­n't in­no­va­tion or speed

Zachary Brennan

Senior Editor

There’s “no ques­tion” that the US is the top phar­ma in­no­va­tor for the world, FDA com­mis­sion­er Robert Califf said yes­ter­day at the Milken In­sti­tute’s Fu­ture …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times